Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Reproductive Biology and Endocrinology

Fig. 1

From: Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice

Fig. 1

Astragaloside IV (AS-IV) attenuates gestational diabetes mellitus (GDM) symptoms in GDM mice. a Chemical structure of Astragaloside IV (AS-IV). Maternal body weight (b), serum glucose level (c) and insulin level (d) were measured on gestation day (GD) 0, 7 and 14 in wild-type group, GDM groups treated with vehicle or AS-IV. Pregnant GDM mice were divided into three groups: Vehicle group (orally gavaged with water), AS-IV (low) group (orally gavaged with AS-IV, 15 mg/kg) and AS-IV (high) group (orally gavaged with AS-IV, 30 mg/kg), mice were treated daily and blood samples were collected from the tails using capillary tubes for examination. Data were presented as mean ± SD. n = 8. * p < 0.05, ** p < 0.01, *** p < 0.001, vs vehicle-treated GDM mice

Back to article page